angiotensin ii has been researched along with gsk-2816126 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, W; Chen, L; Fang, G; Gu, Y; Li, Y; Liu, L; Mo, B; Song, S; Wan, Y; Wang, Q; Wang, Y; Yu, Y; Zhang, R | 1 |
1 other study(ies) available for angiotensin ii and gsk-2816126
| Article | Year |
|---|---|
EZH2 as a novel therapeutic target for atrial fibrosis and atrial fibrillation.
Topics: Angiotensin II; Animals; Atrial Fibrillation; Disease Models, Animal; Dogs; Enhancer of Zeste Homolog 2 Protein; Female; Fibroblasts; Fibrosis; Gene Expression Regulation; Heart Atria; Humans; Indoles; Male; Mice; Middle Aged; Pyridones | 2019 |